Atlas Trials

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

Clinical trial NCT01162096 · COMPLETED

Trial details

NCT number
NCT01162096
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematological Malignancies
Start date
2006-09-01
Primary completion
2010-09-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.